Abstract
Patient Derived Xenografts (PDX) Recapitulate Ruxolitinib Clinical Trial Responses and Identify a Novel Combination Therapy for Chronic Myelomonocytic Leukemia (CMML)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have